Older reports suggest that cytokeratin 20 (CK20) and gastrine-releasing peptide (GRP) expression can also be used to identify MTC-derived CTCs with good sensitivity and specificity [82]. This evidence concerns the gene KRT20 and medullary thyroid gland carcinoma.